2-[1-(o-tolylcarbamoyl)-4-oxo-azetidin-2-yl]acetic acid

ID: ALA4589062

Cas Number: 2023788-32-9

PubChem CID: 154734317

Product Number: I646298, Order Now?

Max Phase: Preclinical

Molecular Formula: C13H14N2O4

Molecular Weight: 262.26

Molecule Type: Unknown

In stock!

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccccc1NC(=O)N1C(=O)CC1CC(=O)O

Standard InChI:  InChI=1S/C13H14N2O4/c1-8-4-2-3-5-10(8)14-13(19)15-9(6-11(15)16)7-12(17)18/h2-5,9H,6-7H2,1H3,(H,14,19)(H,17,18)

Standard InChI Key:  NMHXECODTXNHIV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
   34.0423   -4.5821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8783   -4.5821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8783   -5.4066    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.0423   -5.4066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4587   -5.9902    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.4619   -5.9902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2547   -5.7767    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.8382   -6.3603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6354   -6.1472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2156   -6.7290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0022   -7.5221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2114   -7.7362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6276   -7.1580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8488   -5.3502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2485   -6.7872    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.4619   -4.0028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2485   -3.2058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8320   -2.6223    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.4514   -2.9923    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  3  4  1  0
  4  1  1  0
  4  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
  8 13  1  0
  9 14  1  0
  6 15  2  0
  2 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
M  END

Alternative Forms

  1. Parent:

Associated Targets(Human)

ITGB1 Tclin Integrin alpha-4/beta-1 (2269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-5/beta-1 (686 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-IIb/beta-3 (3481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-24 (129 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEL (6614 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-5 (589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-6 (509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAL Tclin Integrin alpha-L/beta-2 (LFA-1) (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 262.26Molecular Weight (Monoisotopic): 262.0954AlogP: 1.60#Rotatable Bonds: 3
Polar Surface Area: 86.71Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.09CX Basic pKa: CX LogP: 1.32CX LogD: -1.79
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.81Np Likeness Score: -0.88

References

1. Martelli G, Baiula M, Caligiana A, Galletti P, Gentilucci L, Artali R, Spampinato S, Giacomini D..  (2019)  Could Dissecting the Molecular Framework of β-Lactam Integrin Ligands Enhance Selectivity?,  62  (22): [PMID:31670514] [10.1021/acs.jmedchem.9b01000]
2. Baiula M,Galletti P,Martelli G,Soldati R,Belvisi L,Civera M,Dattoli SD,Spampinato SM,Giacomini D.  (2016)  New β-Lactam Derivatives Modulate Cell Adhesion and Signaling Mediated by RGD-Binding and Leukocyte Integrins.,  59  (21): [PMID:27726366] [10.1021/acs.jmedchem.6b00576]

Source